Citizens Maintains Market Outperform on Blend Labs, Lowers Price Target to $4

Benzinga Newsdesk www.benzinga.com Negative 93.6%

Neg 93.6% Neu 0% Pos 0%

Citizens analyst Aaron Kimson maintains Blend Labs (NYSE:BLND) with a Market Outperform and lowers the price target from $5 to $4.